Study of Proteomic Factors in Patients With Severe Dry Eye Syndrome Treated With Autologous Serum Eye Drops.

Inclusion Criteria

• •Age over 18 years
• •Patients with severe dry eye with an Oxford score \> 1
• •Patients with dry eye syndrome refractory to conventional treatments: tear substitutes, immunosuppressive eye drops or corticosteroids.
• •AS-naïve patients followed by an ophthalmologist at Saint-Etienne University Hospital
• •Patients affiliated to or entitled under a social security scheme
• •Patients who have received informed information about the study